CDKN2A Mutations and Melanoma Risk in the Icelandic Population

BACKGROUND: Germline CDKN2A mutations have been observed in 20-40% of high-risk melanoma-prone families, however little is known about their prevalence in population-based series of melanoma cases and controls. METHODS: We resequenced the CDKN2A gene, including the p14ARF variant and promoter region...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Goldstein, Alisa M., Stacey, Simon N., Olafsson, Jon H., Jonsson, Gudbjörn F., Helgason, Agnar, Sulem, Patrick, Sigurgeirsson, Bardur, Benediktsdottir, Kristrun R., Thorisdottir, Kristin, Ragnarsson, Rafn, Kjartansson, Jens, Kostic, Jelena, Masson, Gisli, Kristjansson, Kristleifur, Gulcher, Jeffrey R., Kong, Augustine, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Tucker, Margaret A., Stefansson, Kari
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236640/
https://ncbi.nlm.nih.gov/pubmed/18178632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2007.055376
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky